If you've been hunting for a serious, research-grade peptides UAE source — one that actually holds tesamorelin in stock, ships cold-chain across the Emirates, and doesn't ghost you after checkout — you're in the right place. REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials in Dubai right now, with same-day dispatch to Dubai Marina, JBR, Business Bay, Downtown Dubai, Palm Jumeirah, DIFC, JVC, Emirates Hills, Arabian Ranches, Mirdif, Al Barsha and Dubai Hills, and 24-hour cold-chain courier to Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. This post is the month-by-month log everyone asks for when they're deciding whether to order tesamorelin Dubai or keep scrolling.
Tesamorelin is a 44-amino-acid GHRH analog — a growth hormone releasing hormone fragment that drives pulsatile GH and a measurable IGF-1 rise. Its claim to fame in the published literature is visceral adipose tissue (VAT) reduction in the Stanley 2014 lipodystrophy trials and the earlier Falutz 2007/2010 work. But what the trials don't tell you is the order in which subjects notice changes. That's what this log is for.
To keep the log replicable, the protocol stuck to the most-cited tesamorelin research dose. Every variable was held constant; only time elapsed.
| Variable | Setting |
|---|---|
| Vial | REVIVE LAB UAE tesamorelin 5 mg, lyophilized |
| Reconstitution | BAC water 3 mL (bacteriostatic water) |
| Concentration | ~1.67 mg/mL after reconstitution |
| Dose | 2 mg nightly, subcutaneous (SC) |
| Syringe | 1 mL insulin syringe, 29G or 31G needle |
| Timing | Pre-bed, fasted ~2 h post-meal |
| Storage | Reconstituted vial — fridge 2–8°C |
| Duration | 4 months (16 weeks) |
Almost everyone running tesamorelin notices the same thing first, and it's not fat loss — it's deep sleep. Within 7–14 days the log shows a clear pattern: faster sleep onset, denser slow-wave sleep on the wearable, and waking before the alarm without grogginess. This tracks with what you'd expect from a GHRH analog — pulsatile GH release peaks during stage-3 sleep, and tesamorelin amplifies that pulse.
Practical notes from week 1–4 of the log:
This is the window where most people quit because they expect visible fat loss in 14 days. They don't get it — tesamorelin is a slow-burn peptide. The Stanley 2014 cohort needed 26 weeks for full VAT effect. If you're 4 weeks in and your sleep is better, you're on schedule.
This is where the Stanley 2014 magic shows up. By week 6–8 the log records a tape-measure change at the umbilicus that is not matched by the subcutaneous calliper at the flanks. That's the tesamorelin signature: VAT (the deep belly fat) drops before subcutaneous fat does. Visually it shows up as a flatter morning waist before the love handles do anything.
Falutz 2007 and 2010 documented mean VAT reductions of ~15–18% at 26 weeks with 2 mg/day — so an 8-week timepoint should show roughly a third of that effect. The log was directionally consistent.
| Marker | Baseline | Week 8 | Delta |
|---|---|---|---|
| Morning waist (cm, umbilicus) | 92.0 | 88.5 | −3.5 cm |
| Flank calliper (mm) | 22 | 21 | −1 mm |
| Deep-sleep min (avg/night) | 62 | 83 | +21 min |
| Fasting IGF-1 (ng/mL)* | 168 | 241 | +73 |
*Optional bloodwork at week 8 for protocol adherence; see our IGF-1 monitoring guide.
Month 3 is where the cosmetic dividend lands. Sustained IGF-1 elevation plus better sleep starts showing up in skin: undereyes look less hollow, nail growth picks up, and gym recovery time between hard sessions shortens. Nobody in the published GHRH literature ran a controlled skin trial on tesamorelin specifically, so treat this as observational — but it lines up with what GH-axis modulation does mechanistically.
If you stack peptides smart, this is also the window where adding GHK-Cu (50 mg or 100 mg vials, also stocked at REVIVE LAB UAE) compounds the skin signal. Pickart 2018 mapped GHK-Cu's collagen and fibroblast modulation pathway, and it pairs cleanly with the GH-axis lift from tesamorelin without competing receptors.
By month 4 the body comp picture is fully formed: VAT is meaningfully down, subcutaneous fat is finally responding, and — critically — lean mass is preserved or slightly up. This is the contrast vs a GLP-1 cut, which famously sheds lean tissue alongside fat. Tesamorelin's GH-axis route protects muscle, which is exactly why people stack it under a retatrutide or semaglutide cut.
If you're running a GLP-1 in parallel, read the GLP-1 muscle-loss + tesamorelin strategy post. If you want the full GH-axis comparison, the tesamorelin vs sermorelin vs CJC-1295 breakdown is the next read.
| Month | Primary marker | What you actually notice |
|---|---|---|
| 1 (Wks 1–4) | Deep sleep, vivid dreams, faster onset | Wearable deep-sleep up ~20%, wake refreshed |
| 2 (Wks 5–8) | Visceral adipose tissue (VAT) reduction | Morning waist drops 2–4 cm; calliper slower |
| 3 (Wks 9–12) | Skin glow, nail growth, recovery | Undereye fullness, shorter DOMS, denser nails |
| 4 (Wks 13–16) | Lean-mass-preserving recomp | Visible waist drop without strength loss |
Speed matters when you're starting a 16-week protocol — delaying week 1 by a fortnight throws the entire log out of sync. REVIVE Peptides UAE dispatches every confirmed order the same business day from our Dubai hub. Coverage:
REVIVE LAB UAE is a UAE-based research peptides supplier built specifically for the Emirates market. We hold tesamorelin 5 mg and 10 mg vials in cold storage in Dubai, every vial is HPLC-tested before release, packaging is anonymous and cold-chain shipped, and same-day Dubai dispatch is standard, not premium. If you've been burned by international resellers, lost vials in customs, or paid for “in stock” that turned out to mean 3-week pre-order, this is the fix. Browse all REVIVE Peptides UAE products or jump straight to the REVIVE LAB UAE tesamorelin 5 mg and 10 mg vials page.
REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with same-day dispatch across Dubai (Marina, JBR, Business Bay, Downtown, Palm Jumeirah, JVC, Mirdif, Al Barsha, Dubai Hills) and 24-hour cold-chain courier to Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. COD UAE is available on most routes.
The published research (Stanley 2014, Falutz 2007/2010) and our internal 4-month log agree: sleep changes in weeks 2–4, VAT reduction measurable by weeks 6–8, skin and recovery in weeks 9–12, full recomposition by weeks 13–16. Quitting before week 8 is the #1 reason people miss the effect.
Concentration and shelf efficiency. A 10 mg vial reconstituted with BAC water 3 mL gives ~3.33 mg/mL — fewer reconstitutions per protocol, less BAC water used, and better unit economics if you're running the full 16-week log. Both ship from REVIVE Peptides UAE under the same cold-chain protocol.